(Q42717938)

5 November 2017

title

Population pharmacokinetic analysis of risperidone and 9-hydroxyrisperidone with genetic polymorphisms of CYP2D6 and ABCB1. (English)

1 reference

5 November 2017

1 reference

1 reference

Hee-Doo Yoo

1

1 reference

5 November 2017

Hea-Young Cho

2

1 reference

5 November 2017

Sang-No Lee

3

1 reference

5 November 2017

Hwa Yoon

4

1 reference

5 November 2017

Yong-Bok Lee

5

1 reference

5 November 2017

publication date

24 May 2012

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

5 November 2017

published in

1 reference

5 November 2017

volume

39

1 reference

5 November 2017

issue

4

1 reference

5 November 2017

page(s)

329-341

1 reference

Risperidone treatment for juvenile bipolar disorder: a retrospective chart review

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Correlation of tramadol pharmacokinetics and CYP2D6*10 genotype in Malaysian subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

In vitro P-glycoprotein affinity for atypical and conventional antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

A "silent" polymorphism in the MDR1 gene changes substrate specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Discovery of novel functional variants and extensive evaluation of CYP2D6 genetic polymorphisms in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Automated covariate model building within NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Sequence-based CYP2D6 genotyping in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Intramuscular paliperidone palmitate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Single-dose pharmacokinetics of paliperidone extended-release tablets in healthy Chinese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

The drug efflux-metabolism alliance: biochemical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Effect of rifampin, an inducer of CYP3A and P-glycoprotein, on the pharmacokinetics of risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9253-5

Preparation and characterization of nanoparticles containing an atypical antipsychotic agent

21 January 2018

1 reference

12 December 2020

Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model

1 reference

12 December 2020

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

12 December 2020

Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers

1 reference

12 December 2020

Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

Biochemical profile of risperidone, a new antipsychotic

1 reference

12 December 2020

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

1 reference

12 December 2020

Absorption, metabolism, and excretion of risperidone in humans.

1 reference

12 December 2020

Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes.

1 reference

12 December 2020

Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4

1 reference

12 December 2020

The pharmacokinetics of paliperidone versus risperidone

1 reference

12 December 2020

10.1007/S10928-012-9253-5

Identifiers

DOI

1 reference

release_g4y4avreirfo7ed3ya3rfb4noq

5 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g4y4avreirfo7ed3ya3rfb4noq

24 November 2022

mapped directly with Wikidata item

1 reference